Drug Database
Back to search

Belgium· BE-AMP-SAM542844-00

Vizimpro 15 mg

A dacomitinib product containing dacomitinib monohydrate, registered in Belgium by Pfizer Europe MA. The same ATC class is registered in 11 of our 19 countries.

ATC L01EB07

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVizimpro 15 mgATCL01EB07REGISTER NO.BE-AMP-SAM542844-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dacomitinib monohydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dacomitinib is registered in 11 of 19 countries.

Countries holding a registration under ATC L01EB07 (dacomitinib), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search dacomitinib products by name

Dacomitinib · ATC L01EB07

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dacomitinib Monohydrate
Manufacturer
Pfizer Europe MA
Country
Belgium (BE)
ATC code
L01EB07
ATC class
Dacomitinib
Defined daily dose
45 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

99 interactions on record for dacomitinib.

Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dacomitinib against other medicinesHow interaction checks work

Dacomitinib · interactions on record

99 records

  • 21 severe
  • 75 moderate
  • 3 minor

Most severe, free to view

  • OmeprazoleA02BC01severe
  • PantoprazoleA02BC02severe
  • LansoprazoleA02BC03severe
  • RabeprazoleA02BC04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dacomitinib in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dacomitinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Vizimpro
  • Liechtenstein · Vizimpro
  • Norway · Vizimpro

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd95797b-86f8-4843-a334-16c9fc2d31ba
GET /v1/drugs/dd95797b-86f8-4843-a334-16c9fc2d31ba?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Vizimpro 15 mg",
  "name_fr": "Vizimpro 15 mg",
  "name_nl": "Vizimpro 15 mg",
  "amp_code": "SAM542844-00",
  "strengths": [
    "15.0000",
    "40.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Dacomitinib Monohydrate",
    "Dacomitinib",
    "Lactose Monohydrate",
    "Sodium Starch Glycolate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dacomitinib",
  "authorisation_numbers": [
    "EU/1/19/1354/001"
  ]
}
API referenceMCP serverPlans

See everything about dacomitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console